• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Risk factors and distribution pattern of lateral lymph node recurrence after central neck dissection for cN1a papillary thyroid carcinoma.中央区颈清扫术后 cN1a 期甲状腺乳头状癌侧颈部淋巴结复发的危险因素及分布模式。
BMC Surg. 2024 Sep 27;24(1):270. doi: 10.1186/s12893-024-02564-3.
2
Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.预测甲状腺乳头状癌中央区淋巴结和侧颈区淋巴结转移的因素。
Clin Transl Oncol. 2019 Nov;21(11):1482-1491. doi: 10.1007/s12094-019-02076-0. Epub 2019 Mar 16.
3
Risk factors for local recurrence following lateral neck dissection for papillary thyroid carcinoma.颈侧区清扫术治疗甲状腺乳头状癌后局部复发的危险因素。
Endocrine. 2019 Feb;63(2):310-315. doi: 10.1007/s12020-018-1788-9. Epub 2018 Oct 19.
4
Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.甲状腺乳头状癌跳跃性转移和侧颈部淋巴结转移的危险因素。
Surgery. 2019 Jul;166(1):55-60. doi: 10.1016/j.surg.2019.01.025. Epub 2019 Mar 12.
5
[Lateral neck lymph node metastasis in cN0 papillary thyroid carcinoma].cN0 期甲状腺乳头状癌的侧颈淋巴结转移
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2012 Aug;47(8):662-7.
6
Occult contralateral central neck metastasis in papillary thyroid carcinoma with preoperatively documented ipsilateral lateral neck metastasis.术前同侧颈侧区转移的甲状腺乳头状癌中隐匿性对侧中央区转移。
Eur J Surg Oncol. 2021 Jun;47(6):1339-1345. doi: 10.1016/j.ejso.2021.01.008. Epub 2021 Feb 27.
7
[Analysis of the patterns of cervical lymph node recurrence in patients with cN0 papillary thyroid carcinoma after central neck lymph node dissection].[中央区颈淋巴结清扫术后cN0期甲状腺乳头状癌患者颈部淋巴结复发模式分析]
Zhonghua Zhong Liu Za Zhi. 2015 Oct;37(10):771-5.
8
Clinicopathological pattern of lymph node recurrence of papillary thyroid cancer. Implications for surgery.甲状腺乳头状癌淋巴结复发的临床病理模式。对手术的影响。
Int J Surg. 2014;12 Suppl 1:S194-7. doi: 10.1016/j.ijsu.2014.05.010. Epub 2014 May 23.
9
Central node dissection from the perspective of lateral neck node metastasis in papillary thyroid carcinoma.甲状腺乳头状癌侧颈部淋巴结转移中央区淋巴结清扫的思考
Auris Nasus Larynx. 2024 Apr;51(2):266-270. doi: 10.1016/j.anl.2023.10.003. Epub 2023 Nov 7.
10
Dissection of Levels II Through V Is Required for Optimal Outcomes in Patients with Lateral Neck Lymph Node Metastasis from Papillary Thyroid Carcinoma.对于因甲状腺乳头状癌发生颈侧区淋巴结转移的患者,为获得最佳疗效需要进行 II 至 V 区的解剖。
J Am Coll Surg. 2016 Jun;222(6):1066-73. doi: 10.1016/j.jamcollsurg.2016.02.006. Epub 2016 Feb 19.

引用本文的文献

1
Feasibility and outcomes of remote-access endoscopic and robotic lateral neck dissection for thyroid cancer: a scoping review.甲状腺癌远程接入内镜和机器人辅助侧颈清扫术的可行性及结果:一项范围综述
Gland Surg. 2025 Mar 31;14(3):543-562. doi: 10.21037/gs-2024-535. Epub 2025 Mar 26.

本文引用的文献

1
Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.评估中央淋巴结比值在预测 N1a 低-中危甲状腺乳头状癌复发中的作用。
Front Endocrinol (Lausanne). 2023 Sep 14;14:1158826. doi: 10.3389/fendo.2023.1158826. eCollection 2023.
2
Risk stratification of lateral neck recurrence for patients with pN1a papillary thyroid cancer.pN1a 期甲状腺乳头状癌患者颈侧区复发的风险分层。
BMC Cancer. 2022 Dec 1;22(1):1246. doi: 10.1186/s12885-022-10326-8.
3
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.2022年欧洲甲状腺协会儿童甲状腺结节和分化型甲状腺癌管理指南。
Eur Thyroid J. 2022 Nov 29;11(6). doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1.
4
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.甲状腺癌临床实践指南(NCCN 指南)2022 年第 2 版。
J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040.
5
Extrathyroidal extension and cervical node infiltration are associated with recurrences and shorter recurrence-free survival in differentiated thyroid cancer: a cohort study.甲状腺外扩展和颈部淋巴结浸润与分化型甲状腺癌的复发及较短的无复发生存期相关:一项队列研究。
Thyroid Res. 2022 Jul 26;15(1):13. doi: 10.1186/s13044-022-00131-7.
6
Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.分析影响甲状腺乳头状癌各侧颈部淋巴结转移的因素。
BMC Surg. 2022 Jun 15;22(1):228. doi: 10.1186/s12893-022-01678-w.
7
Thyroid Cancer Incidence and Mortality Trends in the United States: 2000-2018.美国甲状腺癌发病率和死亡率趋势:2000-2018 年。
Thyroid. 2022 May;32(5):560-570. doi: 10.1089/thy.2021.0662. Epub 2022 Mar 15.
8
Cancer statistics, 2022.癌症统计数据,2022 年。
CA Cancer J Clin. 2022 Jan;72(1):7-33. doi: 10.3322/caac.21708. Epub 2022 Jan 12.
9
Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.CN0 期伴有 1-2 枚中央区淋巴结转移的甲状腺乳头状癌患者侧颈淋巴结转移的危险因素及预测模型。
Front Endocrinol (Lausanne). 2021 Oct 15;12:716728. doi: 10.3389/fendo.2021.716728. eCollection 2021.
10
The value of contrast-enhanced ultrasound for the diagnosis of metastatic cervical lymph nodes of papillary thyroid carcinoma: A systematic review and meta-analysis.超声造影对甲状腺乳头状癌颈侧区淋巴结转移的诊断价值:系统评价和 Meta 分析。
J Clin Ultrasound. 2022 Jan;50(1):60-69. doi: 10.1002/jcu.23073. Epub 2021 Oct 8.

中央区颈清扫术后 cN1a 期甲状腺乳头状癌侧颈部淋巴结复发的危险因素及分布模式。

Risk factors and distribution pattern of lateral lymph node recurrence after central neck dissection for cN1a papillary thyroid carcinoma.

机构信息

Department of General Surgery III, Taihe Hospital, Hubei University of Medicine, 32 Renmin South Road, Shiyan, Hubei, 442000, China.

Department of General Surgery, Xiamen Humanity Hospital Fujian Medical University, 3777 Xianyue Road, Xiamen, Fujian, 361000, China.

出版信息

BMC Surg. 2024 Sep 27;24(1):270. doi: 10.1186/s12893-024-02564-3.

DOI:10.1186/s12893-024-02564-3
PMID:39334088
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11428479/
Abstract

BACKGROUND

The indication and extent of selective lateral neck dissection (LND) for cN1a papillary thyroid carcinoma (PTC) remain uncertain. The present study aimed to identify potential predictors and distribution pattern of lateral lymph node recurrence (LLNR) after central neck dissection in cN1a PTC patients.

METHODS

The cN1a PTC patients who underwent initial central neck dissection at our centre were retrospectively reviewed, and the median follow-up period was 6.8 years. Reoperation with LND was performed when LLNR was confirmed. Risk factors for LLNR were identified, and the metastatic status of each lateral level was recorded.

RESULTS

Of the 310 patients enrolled in the present study, fifty-eight patients (18.7%) presented with LLNR. Six independent factors, including tumour diameter, pathological T4 stage, number of involved central lymph nodes, pTNM stage, extrathyroidal extension, and I treatment (P values < 0.05) were identified via multivariate analysis. LLNR was found at level II in 26 patients (44.8%), level III in 38 patients (65.5%), level IV in 30 patients (51.7%), and level V in 8 patients (13.8%). The number of positive lateral lymph nodes at levels II, III, IV and V was 44 (22.9%), 76 (39.6%), 63 (32.8%), and 9 (4.9%), respectively.

CONCLUSIONS

For cN1a PTC patients who underwent central neck dissection, tumour diameter ≥ 2 cm, pathological T4 stage, number of involved central lymph nodes ≥ 3, pTNM stage III-IV, extrathyroidal extension, and failure to receive I treatment were independent predictors of LLNR, which was more likely to occur at levels III and IV.

摘要

背景

cN1a 甲状腺乳头状癌(PTC)选择性颈侧区清扫术(LND)的适应证和范围仍不确定。本研究旨在确定 cN1a PTC 患者行中央区清扫术后颈侧区淋巴结复发(LLNR)的潜在预测因素和分布模式。

方法

回顾性分析在本中心行初次中央区清扫术的 cN1a PTC 患者,中位随访时间为 6.8 年。当确认有 LLNR 时,行 LND 再次手术。确定 LLNR 的危险因素,并记录每个侧区水平的转移状态。

结果

本研究纳入 310 例患者,58 例(18.7%)出现 LLNR。多因素分析确定了 6 个独立的危险因素,包括肿瘤直径、病理 T4 期、中央区淋巴结受累数目、pTNM 分期、甲状腺外侵犯和 I 治疗(P 值均<0.05)。26 例(44.8%)在 II 区、38 例(65.5%)在 III 区、30 例(51.7%)在 IV 区、8 例(13.8%)在 V 区发现 LLNR。II、III、IV 和 V 区阳性侧区淋巴结数目分别为 44(22.9%)、76(39.6%)、63(32.8%)和 9(4.9%)。

结论

对于行中央区清扫术的 cN1a PTC 患者,肿瘤直径≥2cm、病理 T4 期、中央区淋巴结受累数目≥3、pTNM 分期 III-IV 期、甲状腺外侵犯、以及未接受 I 治疗是 LLNR 的独立预测因素,更有可能发生在 III 区和 IV 区。